New‐onset acral lesions on hands after administration of mRNA‐1273 vaccine against SARS‐CoV‐2: clinical images and histopathological study of three cases
Open Access
- 2 August 2021
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (11) , E747-E749
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 casesJournal of the American Academy of Dermatology, 2021
- New-onset chilblains in close temporal association to mRNA-1273 vaccinationJAAD Case Reports, 2021
- BNT162b2 mRNA COVID‐19 vaccine‐induced chilblain‐like lesions reinforces the hypothesis of their relationship with SARS‐CoV‐2Journal of the European Academy of Dermatology and Venereology, 2021
- Acral chilblain‐like lesions following inactivated SARS‐CoV‐2 vaccinationInternational Journal of Dermatology, 2021
- Chilblain lesions after COVID‐19 mRNA vaccineBritish Journal of Dermatology, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Non-viral COVID-19 vaccine delivery systemsAdvanced Drug Delivery Reviews, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 casesBritish Journal of Dermatology, 2020